BD reports FY26 revenues of $19.5bn after medtech prioritisation
Becton, Dickinson and Company (BD) has reported revenues of $19.5bn in fiscal year 2026 (FY26), reflecting a 4.9% rise year-over-year…
News
Edwards Lifesciences raises 2026 outlook after Q3 exceeds growth expectations
Arkstone introduces AI platform for infectious disease guidance
Laza Medical secures $160m to advance robotic imaging system
Zimmer Biomet stock rises 9% after reporting positive Q3
Philips reports positive Q3; outlines €288m recall settlement with DoJ
Trump’s healthcare plans under contention after Democrats’ midterm landslide
GE HealthCare adds new capabilities for Vscan Air ultrasound system
